Purpose

A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements. 2. Patient has been or is intended to be treated with the TBE Device in Zone 0 or Zone 1. 3. Patient is age ≥ 18 years at time of informed consent signature.

Exclusion Criteria

  1. Patient who is, at the time of consent, unlikely to be available for defined follow-up visits. 2. Patient with exclusion criteria required by local law. 3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or investigational device study within 12 months of study enrollment. Subjects cannot be enrolled in another Gore study.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Intervention Model Description
GORE® TAG® Thoracic Branch Endoprosthesis (TBE)
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Other
GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device)
  • Device: GORE® TAG® Thoracic Branch Endoprosthesis
    Lesions in aortic arch in Zone 0 or Zone 1

Recruiting Locations

Lakeland Regional Medical Center
Lakeland, Florida 33805
Contact:
Mohammed Hassan, MD
863-413-5969
mohammed.hassan@mylrh.org

University of Washington Medical Center
Seattle, Washington 98195
Contact:
Matthew Sweet, MD
206-598-8487
mpsweet@uw.edu

More Details

Status
Recruiting
Sponsor
W.L.Gore & Associates

Study Contact

DeAnne Hart
800-437-8181
tbe25-03@wlgore.com

Detailed Description

Minimum of 125 total subjects with a TBE Device implantation procedure initiated in up to 50 Sites in the United States. Subjects will have follow-up at 1 Month, 6 Month, 1 Year, and annually thereafter for a minimum of 5-years and up to a maximum of 10 years.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.